(Adds details of the deal, background, share move)
BENGALURU, March 16 (Reuters) -
Indian drugmaker Eris Lifesciences Ltd ERIS.NS said on
Thursday it had bought nine dermatology brands from Dr. Reddy's
Laboratories Ltd REDY.NS in a 2.75 billion rupees ($33.24
million) deal, to expand in the cosmetic dermatology business.
The deal, to be paid in cash, is expected to be
completed on or before March 31, Eris
said
in a stock exchange filing.
Eris and Dr. Reddy's did not immediately respond to
Reuters' requests seeking the names of the dermatology brands.
The deal comes two months after Eris
said
it would acquire a portfolio of dermatology brands from
Glenmark Pharmaceuticals Ltd GLEN.NS for 3.4 billion rupees to
deepen its presence in the anti-fungal and anti-psoriasis
segments.
Eris' shares were trading 1.4% lower as of 2:33 p.m. IST
and were headed for a sixth straight session of losses. They
have fallen 9.2% since announcing the deal with Glenmark.
($1 = 82.7250 Indian rupees)
(Reporting by Yagnoseni Das and Hritam Mukherjee in Bengaluru;
Editing by Rashmi Aich and Eileen Soreng)
((Yagnoseni.Das@thomsonreuters.com; +91 6001289066;))